| 2024-06-07 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 35,000 0.0603% | $35.19 | $1.23M | -6.35% | |
| 2024-04-01 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 25,000 0.0429% | $28.31 | $707,750 | -0.14% | |
| 2024-03-01 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 30,000 0.051% | $31.62 | $948,600 | -10.36% | |
| 2023-12-13 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 75,000 0.1305% | $20.08 | $1.51M | +39.33% | |
| 2021-12-21 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 15,000 0.0311% | $32.14 | $482,171 | -70.97% | |
| 2021-01-19 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 24,846 0.0557% | $24.60 | $611,105 | +31.22% | |
| 2019-12-03 | Protagonist Therapeutics, Inc. PTGX | President and CEO | 60,000 0.2602% | $5.62 | $337,000 | +243.28% | ||
| 2019-08-06 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 21,584 0.0731% | $8.85 | $191,070 | +5.68% | |
| 2019-03-01 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 4,366 0.0172% | $8.03 | $35,059 | +28.72% | |
| 2019-02-06 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 21,818 0.0893% | $7.74 | $168,820 | +38.82% | |
| 2017-12-21 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 8,210 0.0464% | $19.56 | $160,570 | -55.14% | |
| 2017-12-20 | Sale | Protagonist Therapeutics, Inc. PTGX | President and CEO | 1,790 0.0102% | $19.55 | $34,987 | -54.63% |